- Licensing Guidelines 2020 – Gazetted
- Guidelines on Registration of Imported Herbal medicinal products for Human or Veterinary use
- Guidelines on hand sanitizers for use during the COVID-19 pandemic
- Part 1 GMP Guidelines for Medicinal Products_R3
- Part II GMP Guidelines for Medicinal Products (Basic Requirements for APIs)
- Annexes to GMP Guidelines for Medicinal Products_R2
- Guidelines on detecting & reporting adverse drug reactions in Uganda
- NDA insurance cover Guidelines
- NDA Guidelines on registration of Vaccines
- Guidelines for detecting and reporting ADR
- Guidelines for Variation of Registered Vaccines
- Guidelines for the conduct of clinical trials in Uganda
- Guidelines on Good Clinical Practice in the conduct of Clinical Trials involving human participants
- Guidelines for Renewal of Registration of a Pharmaceutical product
- Guidelines for Adverse Events Following Immunization (AEFI)
- Guidelines for registration of Biotherapeutic products
- Guidelines of registration of Similar Biotherapeutic Products
- Guidelines on Periodic Safety Update Reports_R0
- Guidelines on Good Distribution Practice for Pharmaceutical Products
- Guidelines for introducing a new formulation pharmaceutical product on the Uganda market
- Guidelines for recall of a medical product
Toll Free: 0800 101 999
National Drug Authority
Safe Drugs Save Lives
- Home
- About Us
- Downloads
- DIRECTORATES
- REGISTERS
- Contact Us
Human Medicine Guidelines
You are here:
- Home
- Human Medicine Guidelines
